Business Wire

BioFire Diagnostics Initiates Clinical Study for the FilmArray™ Meningitis/Encephalitis Panel

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, announced today that it has commenced clinical and analytical studies to evaluate the company’s ...
Business Wire

BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray ® Torch, the New High Throughput FilmArray ® System with FilmArray ® Respiratory Panel

MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular ...
Healio

Cerebrospinal fluid test for detecting multiple pathogens gains FDA allowance

Please provide your email address to receive an email when new articles are posted on . The FDA recently allowed marketing of the first cerebrospinal fluid nucleic acid-based panel for concurrent ...
Firefighter Nation

BioFire Awarded Next Generation Diagnostics System Contract

SALT LAKE CITY, Utah (March 26, 2013) — BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next ...
Medscape

FDA OKs Multipathogen Nucleic Acid Test for CNS Infections

The US Food and Drug Administration (FDA) today approved the first nucleic acid-based test of cerebrospinal fluid (CSF) that can simultaneously detect 14 pathogens responsible for central nervous ...